Indegene Limited (BOM: 544172)

Market Cap	161.21B
Revenue (ttm)	27.10B
Net Income (ttm)	3.73B
Shares Out	n/a
EPS (ttm)	16.17
PE Ratio	43.22
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	41,637
Average Volume	25,547
Open	653.20
Previous Close	652.40
Day's Range	647.35 - 676.55
52-Week Range	468.90 - 736.60
Beta	n/a
RSI	65.87
Earnings Date	Jan 27, 2025

About Indegene

Indegene Limited operates as a life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, and Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platfor...

• Industry: Commercial Physical and Biological Research
• Founded: 1998
• Employees: 4,367
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544172

Financial Performance

In 2023, Indegene's revenue was 25.90 billion, an increase of 12.29% compared to the previous year's 23.06 billion. Earnings were 3.37 billion, an increase of 26.53%.